EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Mitophagy modulation for the treatment of cardiovascular diseases

Maurizio Forte, Luca D'Ambrosio, Gabriele G Schiattarella, Nadia Salerno, Marco Alfonso Perrone, Francesco S Loffredo, Edoardo Bertero, Kalliopi Pilichou, Girolamo Manno, Valentina Valenti, Luigi Spadafora, Marco Bernardi und 6 weitere

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Maurizio Forte und 17 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Neuromed, Pozzilli, Italy. Hauptthemen laut MEDLINE: Mitophagy, Cardiovascular Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Center for Gene Therapy and Drugs based on RNA Technology, Ministero dell'Istruzione, dell'Università e della Ricerca, European Union-NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Defects of mitophagy, the selective form of autophagy for mitochondria, are commonly observed in several cardiovascular diseases and represent the main cause of mitochondrial dysfunction. For this reason, mitophagy has emerged as a novel and potential therapeutic target.

Methods

In this review, we discuss current evidence about the biological significance of mitophagy in relevant preclinical models of cardiac and vascular diseases, such as heart failure, ischemia/reperfusion injury, metabolic cardiomyopathy and atherosclerosis.

Results

Multiple studies have shown that cardiac and vascular mitophagy is an adaptive mechanism in response to stress, contributing to cardiovascular homeostasis. Mitophagy defects lead to cell death, ultimately impairing cardiac and vascular function, whereas restoration of mitophagy by specific compounds delays disease progression.

Conclusions

Despite previous efforts, the molecular mechanisms underlying mitophagy activation in response to stress are not fully characterized. A comprehensive understanding of different forms of mitophagy active in the cardiovascular system is extremely important for the development of new drugs targeting this process. Human studies evaluating mitophagy abnormalities in patients at high cardiovascular risk also represent a future challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyCardiovascular DiseasesHumansAtherosclerosisHeart FailureAnimalsMyocardial Reperfusion InjuryCardiomyopathiesMitochondria, Heart

Stichwörter der Autor:innen

autophagyheart failuremetabolic cardiomyopathymitochondrial dysfunctionmitophagymyocardial ischemia

Autor:innen und Institutionen

  • IRCCS Neuromed, Pozzilli, Italy.
  • Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
  • Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
  • Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.

ORCID-Profile: Sebastiano Sciarretta

Förderung

  • National Center for Gene Therapy and Drugs based on RNA Technology
  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • European Union-NextGenerationEU
  • Ministero della Salute
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Forte, M., D'Ambrosio, L., Schiattarella, G. G., Salerno, N., Perrone, M. A., Loffredo, F. S., Bertero, E., Pilichou, K., Manno, G., Valenti, V., Spadafora, L., Bernardi, M., Simeone, B., Sarto, G., Frati, G., Perrino, C., Sciarretta, S., & Italian Society of Cardiology Working Group on Cellular and Molecular Biology of the Heart (2024). Mitophagy modulation for the treatment of cardiovascular diseases. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14199

Vancouver

Forte M, D'Ambrosio L, Schiattarella GG, Salerno N, Perrone MA, Loffredo FS, et al. Mitophagy modulation for the treatment of cardiovascular diseases. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14199

BibTeX
@article{Forte2024,
  author = {Forte, Maurizio and D'Ambrosio, Luca and Schiattarella, Gabriele G and Salerno, Nadia and Perrone, Marco Alfonso and Loffredo, Francesco S and Bertero, Edoardo and Pilichou, Kalliopi and Manno, Girolamo and Valenti, Valentina and Spadafora, Luigi and Bernardi, Marco and Simeone, Beatrice and Sarto, Gianmarco and Frati, Giacomo and Perrino, Cinzia and Sciarretta, Sebastiano and Italian Society of Cardiology Working Group on Cellular and Molecular Biology of the Heart, Italian Society of Cardiology Working Group on Cellular and Molecular Biology of the Heart},
  title = {Mitophagy modulation for the treatment of cardiovascular diseases},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14199}
}
Kostenlos starten →